Effects of pirenzepine on CCK-stimulated canine pancreatic exocrine secretion

Gen Pharmacol. 1990;21(2):195-8. doi: 10.1016/0306-3623(90)90900-7.

Abstract

1. The effects of the anticholinergic compound pirenzepine on pancreatic secretion stimulated by intravenous infusions of increasing doses of CCK (0.025-0.4 Ivy Dog Unit/kg/min) were investigated in fasting anaesthetized dogs. 2. Pirenzepine (0.75 mg/kg i.v.) slightly reduced the increases in the pancreatic juice secretion evoked by CCK. 3. Similar results were obtained with others anticholinergic compounds as atropine (3 mg/kg i.v.) and hexametonium (5 mg/kg i.v.).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amylases / metabolism
  • Anesthesia
  • Animals
  • Atropine / pharmacology
  • Cholecystokinin / pharmacology*
  • Dogs
  • Hexamethonium Compounds / pharmacology
  • Male
  • Pancreas / drug effects
  • Pancreas / metabolism*
  • Pancreatic Juice / metabolism
  • Pirenzepine / pharmacology*

Substances

  • Hexamethonium Compounds
  • Pirenzepine
  • Atropine
  • Cholecystokinin
  • Amylases